Report: Annual visits play role in early MCI, dementia diagnosis
By
Kristen Fischer
Oct 09, 2024
Annual wellness visits may be critical to identify mild cognitive impairment (MCI) early among Medicare beneficiaries, which could drive more proactive care, a new study finds.
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
By
Kristen Fischer
Oct 08, 2024
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% effective in preventing severe illness three years after patients 60 and older first...
Arm position during blood pressure reading can affect accuracy, study finds
By
Kristen Fischer
Oct 07, 2024
The way you’re positioned during a blood pressure reading can affect its accuracy, and supporting your arm on a table is best, a new study finds.
Older stroke survivors experience immediate and long-term cognitive decline, study finds
By
John Roszkowski
Oct 06, 2024
Older adults who have a stroke for the first time experience an immediate and long-term decline in their cognitive function, according to the results of a new study.
Sit less each day to reduce back pain, study finds
By
Kristen Fischer
Oct 03, 2024
A new study suggests that sitting down less each day could be a way to prevent existing back pain from getting worse.
Bemdaneprocel for Parkinson’s benefits users up to two years
By
Kristen Fischer
Oct 02, 2024
Bemdaneprocel, a cell therapy developed for Parkinson’s disease by Bluerock Therapeutics, helped people control symptoms, according to trial data.
More than ADLs: Assisted living now is about treatment, Silverado CEO says
By
Lois A. Bowers
Sep 30, 2024
Assisted living is a “whole different world” compared with 28 years ago, Silverado CEO Loren Shook told those attending a session at the National Investment Center for Seniors Housing & Care’s...
The role of endovascular therapy for stroke patients
By
Donna Shryer
Sep 28, 2024
A recent review article, published in the Lancet, provided a contemporary update of endovascular therapy for stroke patients. The article authors, researchers from Boston University Chobanian & Avedisian...
Promising results from Parkinson’s drug trial
By
Kristen Fischer
Sep 26, 2024
Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson’s disease and improved motor skills, the company reported on Thursday.
Most patients expect antibiotics when they don’t need them, survey finds
By
Kristen Fischer
Sep 25, 2024
Most people expected to receive antibiotics for illnesses that were often caused by viruses, which don’t require them, according to survey results published Monday in the Annals of Family Medicine.